Trial Profile
A clinical trial to investigate the efficacy of CAR-T cell therapy in patients with relapsed or refractory B lymphoblastic leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2016
Price :
$35
*
At a glance
- Drugs Anti cd19 CAR T cell therapy Innovative Cellular Therapeutics (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 07 Jul 2016 New trial record